Biologic degraders push forward in the clinic Apr 21 Written by Jamison Wright https://www.nature.com/articles/d41573-026-00064-y In the News Jamison Wright https://jamisonwright.com Next Next EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors
Biologic degraders push forward in the clinic Apr 21 Written by Jamison Wright https://www.nature.com/articles/d41573-026-00064-y In the News Jamison Wright https://jamisonwright.com
